Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Mar 12;4(3):e004525.
doi: 10.1136/bmjopen-2013-004525.

Randomised Evaluation of modified Valsalva Effectiveness in Re-entrant Tachycardias (REVERT) study

Andrew Appelboam  1 , Adam Reuben, Clifford Mann, Trudie Lobban, Paul Ewings, Jonathan Benger, Jane Vickery, Andrew Barton, James Gagg
Affiliations
Multicenter Study

Randomised Evaluation of modified Valsalva Effectiveness in Re-entrant Tachycardias (REVERT) study

Andrew Appelboam et al. BMJ Open. .

Abstract

Introduction: The Valsalva manoeuvre (VM) is a recommended first-line physical treatment for patients with re-entrant supraventricular tachycardia (SVT), but is often ineffective in standard practice. A failed VM is typically followed by treatment with intravenous adenosine, which patients often find unpleasant. VM effectiveness might be improved by a modification to posture which exaggerates the manoeuvre's vagal response and reduces the need for further emergency treatment.

Methods and analysis: This is a multicentre randomised controlled clinical trial in 10 UK emergency departments (EDs). It compares a standard VM with a modified VM incorporating leg elevation and a supine posture after a standardised strain in stable adult patients presenting to the ED with SVT. The primary outcome measure is return to sinus rhythm on a 12-lead ECG. Secondary outcome measures include the need for treatment with adenosine or other antiarrhythmic treatments and the time patients spend in the ED. We plan to recruit approximately 372 patients, with 80% power to demonstrate an absolute improvement in cardioversion rate of 12%. An improvement of this magnitude through the use of a modified VM would be of significant benefit to patients and healthcare providers, and justify a change to standard practice.

Ethics and dissemination: The study has been approved by the South West-Exeter Research Ethics Committee (REC reference 12/SW/0281). The trial will be published in an international peer reviewed journal. Study findings will be sent to the European and International resuscitation councils to inform future revisions of arrhythmia management guidelines.

Results: The trial will also be disseminated at international conferences and to patients through the Arrhythmia Alliance, a patient support charity.

Registration: The study is registered with Current Controlled Trials (ISRCTN67937027) and has been adopted by the National Institute for Health Research (NIHR) Clinical Research Network.

Keywords: Accident & Emergency Medicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
REVERT study flow diagram.
See this image and copyright information in PMC

References

    1. Orejarena LA, Vidaillet H, DeStefano F, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998;31:150–7 - PubMed
    1. http://www.heartrhythmcharity.org.uk/www/218/0/Patient_stories/ (accessed Jun 2013).
    1. Wood KA, Drew BJ, Scheinman MM. Frequency of disabling symptoms in supraventricular tachycardia. Am J Cardiol 1997;79:145–9 - PubMed
    1. Murman DH, McDonald AJ, Pelletier AJ, et al. US emergency department visits for supraventricular tachycardia, 1993-2003. Acad Emerg Med 2007;14:578–81 - PubMed
    1. Cohn AE, Fraser FR. Paroxysmal tachycardia and the effect of stimulation of the vagus nerves by pressure. Heart 1914;5:93–108

Publication types

LinkOut - more resources